# Biotech Collaboration Strategy With IGI's Cyril Konto, M.D.

Page: https://stenobird.com/podcast/business-of-biotech-123501/biotech-collaboration-strategy-with-igi-s-cyril-konto-m-d
Text version: https://stenobird.com/podcast/business-of-biotech-123501/biotech-collaboration-strategy-with-igi-s-cyril-konto-m-d.md
Podcast: [Business Of Biotech](https://stenobird.com/podcast/business-of-biotech-123501)
Published: 2025-11-24T11:00:00+00:00
Episode link: https://www.buzzsprout.com/1011661/episodes/18217716-biotech-collaboration-strategy-with-igi-s-cyril-konto-m-d.mp3
Audio file: https://www.buzzsprout.com/1011661/episodes/18217716-biotech-collaboration-strategy-with-igi-s-cyril-konto-m-d.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/business-of-biotech-123501/episodes/biotech-collaboration-strategy-with-igi-s-cyril-konto-m-d
Duration seconds: 3521

## Resource

We love to hear from our listeners. Send us a message. On this week's episode, Cyril Konto, M.D., president, executive director, and CEO at Ichnos Glenmark Innovation (IGI) talks about the promise of multi-specific antibodies, funding the company during the 'biotech winter,' closing a $700 million upfront licensing deal with AbbVie, the impact of China's rising biotech sector, and the keys to successful collaboration. Cyril also discusses IGI's focus on developing innovative therapies for em...

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/business-of-biotech-123501/episodes/biotech-collaboration-strategy-with-igi-s-cyril-konto-m-d/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/business-of-biotech-123501/biotech-collaboration-strategy-with-igi-s-cyril-konto-m-d.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.